As laboratory criteria of APS, it proposed to determine a weighted cumulative score of aPLs based on the detection of LAC or semi-quantitative levels of aCL or aβ2GPI IgG/IgM titer, rather than the threshold of the 99th percentile of healthy controls [3]. This evidence concerns the gene LCT and autoimmune polyendocrinopathy.